About Us Contact Us Disclaimer Sitemap
  New Old
HOME TRADING DERIVATIVES PMS MUTUAL FUNDS IPO BONDS RESEARCH MARKET
left «« +1 «« -1 right
 
  Equity Analysis
  Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
  Volume
  Analysis
  News Analysis
Corporate Action
  Corporate Info
  Other Market
 
Company News  
 
Lupin Ltd.
Change Company   
BSE Code 500257
ISIN Demat INE326A01037
Book Value(Rs.) 385.64
NSE Code LUPIN
Dividend Yield % 0.70
Market Cap(Rs. in millions) 389998.10
P/E 53.60
EPS 16.06
Face Value(Rs.) 2  
08-Jul-2020 Lupin recalls all batches of Metformin Hydrochlor...
08-Jul-2020 Lupin informs about disclosure
08-Jul-2020 Lupin surges on the bourses
15-Jun-2020 Lupin planning to approach USFDA for re-inspectio...
15-Jun-2020 Lupin moves up on planning to approach USFDA for ...
12-Jun-2020 Lupin gets USFDA’s nod for Albendazole Tablets
12-Jun-2020 Biocon, Wipro and Lupin to see some action today
08-Jun-2020 USFDA grants mexiletine orphan drug designation t...
08-Jun-2020 Lupin inches up as USFDA grants mexiletine orphan...
08-Jun-2020 Lupin informs about press release
05-Jun-2020 Lupin, Mylan receive European Marketing Authoriza...
05-Jun-2020 Lupin jumps on receiving European Marketing Autho...
05-Jun-2020 Reliance Industries, Lupin and HCL Technologies t...
03-Jun-2020 Lupin receives USFDA’s approval for Meloxicam Cap...
03-Jun-2020 Lupin signs distribution agreement in key EU terr...
Page 1 of 5
Prev || Next
 
Terms & Conditions Copyright ©ATLAS All rights reserved. Designed || Developed & Content Powered By Accord Fintech Pvt.Ltd.

Important Links : SEBI | NSE | BSE | RBI | CDSL | NSDL | Investor Grievance| Policy
SEBI REG. NO. NSE : CASH INZ000166836; FO INZ000166836| BSE : CASH INZ000166836; FO INZ000166836
PMS : INP000000530 | AMFI : ARN0770 | CDSL : IN-DP-CDSL-465-2008